Alpha 2.0
Login Register
» Articles » PMID: 15570574

Post-treatment Emergent Adverse Events in Depressed Patients Following Treatment with Milnacipran and Paroxetine

Overview
Journal Hum Psychopharmacol
Specialty Pharmacology
Date 2004 Dec 1
PMID 15570574
Citations 7
Authors
P Vandel
D Sechter
E Weiller
N Pezous
F Cabanac
A Tournoux
E Panconi
Affiliations
Soon will be listed here.
Citing Articles

Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.

Zhang M, Tan X, Zheng Y, Zeng N, Li Z, Horowitz M Mol Psychiatry. 2024; .

PMID: 39394455 DOI: 10.1038/s41380-024-02782-4.

Antidepressant Withdrawal and Rebound Phenomena.

Henssler J, Heinz A, Brandt L, Bschor T Dtsch Arztebl Int. 2019; 116(20):355-361.

PMID: 31288917 PMC: 6637660. DOI: 10.3238/arztebl.2019.0355.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni L, Rizzo C Cochrane Database Syst Rev. 2014; (4):CD006531.

PMID: 24696195 PMC: 10091826. DOI: 10.1002/14651858.CD006531.pub2.

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression.

Kamijima K, Hashimoto S, Nagayoshi E, Koyama T Neuropsychiatr Dis Treat. 2013; 9:555-65.

PMID: 23650446 PMC: 3640608. DOI: 10.2147/NDT.S42915.

Milnacipran: a unique antidepressant?.

Kasper S, Pail G Neuropsychiatr Dis Treat. 2010; 6:23-31.

PMID: 20856597 PMC: 2938282. DOI: 10.2147/NDT.S11777.